The Role of Standards in Supporting Quality Vaccines Manufacturing and Distribution
Biotech
Information
The scale and speed of the global vaccine research and development effort in response to COVID-19 is unprecedented. Researchers are exploring many different types of platforms for the development of COVID-19 vaccines, from the more traditional live attenuated virus and inactivated virus approaches, to recombinant protein antigen candidates, to newer approaches such as nucleic acid vaccines, like mRNA, which are showing promise in early stage phase 1 and 2 clinical trials. USP's John Kokai-Kun, Ph.D., Director, External Scientific Collaboration-Biologics, discusses the role public quality standards play in supporting quality vaccine manufacturing and distribution. Click to read more.
